sodium salicylate has been researched along with thromboplastin in 3 studies
| Studies (sodium salicylate) | Trials (sodium salicylate) | Recent Studies (post-2010) (sodium salicylate) | Studies (thromboplastin) | Trials (thromboplastin) | Recent Studies (post-2010) (thromboplastin) |
|---|---|---|---|---|---|
| 2,031 | 50 | 171 | 10,540 | 281 | 2,126 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mackman, N; Oeth, P | 1 |
| Foss, KB; Joø, GB; Kierulf, P; Okkenhaug, C; Osnes, LT; Ovstebø, R; Westvik, AB | 1 |
| Buchan, KW; Pike, NB; Sumner, MJ | 1 |
3 other study(ies) available for sodium salicylate and thromboplastin
| Article | Year |
|---|---|
Salicylates inhibit lipopolysaccharide-induced transcriptional activation of the tissue factor gene in human monocytic cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Base Sequence; Cell Line; DNA Primers; Humans; In Vitro Techniques; Lipopolysaccharides; Molecular Sequence Data; Monocytes; NF-kappa B; Promoter Regions, Genetic; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-rel; RNA, Messenger; Salicylates; Sodium Salicylate; Thromboplastin; Transcription Factor RelA; Transcriptional Activation | 1995 |
Acetylsalicylic acid and sodium salicylate inhibit LPS-induced NF-kappa B/c-Rel nuclear translocation, and synthesis of tissue factor (TF) and tumor necrosis factor alfa (TNF-alpha) in human monocytes.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biological Transport; Cells, Cultured; Humans; Monocytes; NF-kappa B; Sodium Salicylate; Thromboplastin; Tumor Necrosis Factor-alpha | 1996 |
Sodium salicylate enhances expression of tissue factor (TF) in human adherent monocytes and in whole blood.
Topics: Cell Adhesion; Humans; Monocytes; Sodium Salicylate; Thromboplastin | 1998 |